Open Label Phase I Trial of intramyocardial AMG0001-01 administration in chronic heart failure patients with ischemic cardiomyopathy

Trial Profile

Open Label Phase I Trial of intramyocardial AMG0001-01 administration in chronic heart failure patients with ischemic cardiomyopathy

Discontinued
Phase of Trial: Phase I

Latest Information Update: 29 Jul 2016

At a glance

  • Drugs Beperminogene perplasmid (Primary)
  • Indications Ischaemic heart disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jul 2016 Status changed from recruiting to discontinued.
    • 22 Oct 2014 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan
    • 24 Jul 2014 Planned initiation date changed from 1 Jul 2014 to 1 Oct 2014 as reported by University Hospital Medical Information Network - Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top